Latest Blogs

Aug 05, 2020
Hospitals and clinics are restricting visitors to limit the risk of exposure to COVID-19, but this precaution can be difficult for family caregivers who are struggling to get the information they need to help their loved ones.
Aug 04, 2020
Ahead of the ASCO20 Virtual Education Program, Mr. David Whitaker of Choose Chicago sends his best wishes and gratitude on behalf of the city where the ASCO Annual Meeting is traditionally held.
Jul 27, 2020
Ten years after losing my mom to breast cancer, I find myself reflecting on who I am today and what I have learned from the loss and grief that propelled me to relocate across the globe and dedicate my career to serving patients with cancer. 
Jul 23, 2020
Sometimes the best treatment isn't a medical intervention, but an emotional one, as Dr. Dawood Findakly discovered when a patient seemed to lose his will to live.
Subscribe to this column

Peter Paul Yu, MD, FASCO, FACP

Peter Paul Yu, MD, FACP, FASCO, is the physician-in-chief at Hartford HealthCare Cancer Institute. He is a past president of ASCO, past chair of the Breakthrough Co-Host Committee, and currently serves on the CancerLinQ Board of Governors, as an associate editor of JCO Clinical Cancer Informatics, and on the JCO Oncology Practice editorial board. Follow Dr. Yu on Twitter @YupOnc.

Mar 11, 2012
In health care, we often find ourselves reacting to events rather than dictating them. Being cast in this undesirable position is often unavoidable when dealing with regulators and federal policy. However, the ability to foresee the need for change and thereby influence the direction of change is a...
Nov 20, 2011
This week the FDA decided to withdraw bevacizumab's indication for treatment of metastatic breast cancer. The earlier indication had been approved under FDA's accelerated approval process wherein final approval was conditional on the generation of confirmatory evidence based on clinical trials.
Nov 06, 2011
Let me start by mentioning 2 things I missed earlier about Day 1 of the ASCO HIT/EHRs Symposium.  In the session on Usability, Karen Bell, Chair of CCHIT, mentioned 3 areas where EHRs may impact malpractice risk; Communications, Documentation and Medical Errors. Each of these has the potential to...
Nov 06, 2011
The November 3rd edition of the NEJM features a Perspective article on drug shortages by Mandy Gatesman and Thomas J Smith (NEJM 365:18 page 163) that address many of the causative issues that underlie this growing national problem.  
Nov 04, 2011
Today was day 1 of the ASCO HIT/EHR Symposium, which covered a wide range of the ever changing HIT landscape.  Paul Tang, Vice Chair of the ONC HIT Policy Committee, and Chuck Friedman, former Chief Scientific Officer of ONC, now Director of Health Informatics at the U. Michigan School of Public...

Pages